Type of securities : Common share | Effective Date : 31/01/2022 | Close Selling Date : 07/02/2022
ประเภทหลักทรัพย์ : หุ้นสามัญ | วันที่มีผลใช้บังคับ : 31/01/2565 | วันที่ปิดการขาย : 07/02/2565
(10.68) Operating cost 596.69 621.42 (24.73) Gross profit 110.53 96.48 14.05 Gross profit margin 15.63% 13.44% 2.19% Other income 3.80 1.99 1.81 Selling expenses 2.13 3.04 (0.91) Administrative expenses
11.93 29.77 (17.84) (59.93) Gross Profit Margin (%) 25.43 26.46 Net Profit Margin (%) 5.27 11.72 Remark: 1) Net profit margin is calculated from the net profit attributable to equity holders of the parent
Profit - attributable to equity holders of the parent 14.56 24.26 (9.70) (39.98) Gross Profit Margin (%) 24.51 27.10 Net Profit Margin (%) 6.70 9.88 Unit: million Baht For 6-month period (Jan-Jun) 2020
115.40% Gross profit margin 61.51% 59.98% 1.53% Net profit margin 45.50% 36.59% 8.91% บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2
tax expenses (revenues) 0.28 0.04 0.24 600.00% Net profit 72.74 27.07 45.67 168.71% Gross profit margin 63.46% 59.09% 4.38% Net profit margin 46.22% 34.87% 11.35% 1. Revenues from sales The Company
tax expenses (revenues) 1.32 0.48 0.84 175.00% Net profit 112.11 54.54 57.57 105.56% Gross profit margin 62.21% 62.82% Net profit margin 47.84% 45.82% 1. Revenues from sales The Company recorded
170.45 142.90 27.54 Gross profit margin 15.33% 13.51% 1.82% Other income 4.77 3.67 1.09 Selling expenses 2.66 4.73 (2.07) Administrative expenses 80.76 84.95 (4.19) Earnings before interest and tax 91.79
, +13.4% YoY and +12.6% QoQ. Q1’19 Net profit* margin was at 14.0%, +120 bps YoY and +150 bps QoQ. - Overall Q1’19 Net Sales were at THB 6,366 million, or +4.2% YoY, driven by all business units. Domestic